Showing results (761-770 of 803) with videos related to
Sort By:
Pageof 81
The Lancet. Microbe|January 29, 2024
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysisZoe Raglow, Diya Surie, James D Chappell, et al.Journal of Hepatology|July 24, 2017
Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre studyHarry R Dalton, Jeroen J J van Eijk, Pascal Cintas, et al.Blood|January 23, 2026
DHODH as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALLYuxuan Liu, Haowen Jiang, Jingjing Liu, et al.Nature Medicine|July 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trialMichael Lim, Xiaobu Ye, Anna F Piotrowski, et al.Nature Immunology|January 21, 2022
The immunoregulatory landscape of human tuberculosis granulomasErin F McCaffrey, Michele Donato, Leeat Keren, et al.Nature Communications|April 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignanciesPablo Domizi, Jolanda Sarno, Astraea Jager, et al.ACS Chemical Biology|July 2, 2014
Phylogenomically guided identification of industrially relevant GH1 β-glucosidases through DNA synthesis and nanostructure-initiator mass spectrometryRichard A Heins, Xiaoliang Cheng, Sangeeta Nath, et al.Plos Biology|May 5, 2026
Surveillance on California dairy farms reveals multiple possible sources of H5N1 influenza virus transmissionA J Campbell, Meredith Shephard, Abigail P Paulos, et al.Nature Machine Intelligence|December 9, 2020
Integration of mechanistic immunological knowledge into a machine learning pipeline improves predictionsAnthony Culos, Amy S Tsai, Natalie Stanley, et al.Nature Medicine|September 13, 2022
Post-infusion CAR T<sub>Reg</sub> cells identify patients resistant to CD19-CAR therapyZinaida Good, Jay Y Spiegel, Bita Sahaf, et al.Pageof 81